ID   SGF-8
AC   CVCL_A1RY
DR   Wikidata; Q105511057
RX   DOI=10.5833/jjgs.28.615;
RX   PubMed=10937344;
CC   Population: Japanese.
CC   Characteristics: Established from a xenograft transplanted into BALB/c,nu/nu mice.
CC   Doubling time: 38.5 hours (DOI=10.5833/jjgs.28.615; PubMed=10937344).
CC   Caution: Indicated as originating from a 56 year old male patient in DOI=10.5833/jjgs.28.615 and from a 52 year old male patient in PubMed=10937344.
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C4024; Esophageal squamous cell carcinoma
DI   ORDO; Orphanet_99977; Squamous cell carcinoma of the esophagus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   56Y
CA   Cancer cell line
DT   Created: 12-01-21; Last updated: 10-09-24; Version: 6
//
RX   DOI=10.5833/jjgs.28.615;
RA   Fujimaki, Masao
RT   "Surgical treatment of esophageal cancer: preclinical and clinical
RT   aspects.";
RL   Nihon Shokaki Geka Gakkai Zasshi 28:615-626(1995).
//
RX   PubMed=10937344;
RA   Yokoyama, Yoshinobu
RA   Saito, Mitsukazu
RA   Saito, Tomohiro
RA   Yuguchi, Takashi
RA   Sawataishi, Masaru
RA   Sakamoto, Takashi
RA   Tazawa, Kenji
RA   Tsukada, Kazuhiro
RT   "Synergistic antiproliferative effect of delta 12-prostaglandin J2
RT   (delta 12-PGJ2) and hyperthermia on human esophageal cancer cell
RT   lines.";
RL   Hum. Cell 13:23-33(2000).
//